该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-09-18 AccNo: 0001193125-18-276417 Size: 18 KBItem 2.01: Completion of Acquisition or Disposition of AssetsItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 内部交易: 2018-09-04,总裁 & CEO,KLOSK STEVEN M ,卖出,55000普通股, $66.30
$凯姆布雷克斯(CBM)$ 内部交易: 2018-09-04,总裁 & CEO,KLOSK STEVEN M ,期权,55000普通股, $17.81
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-20,EVP & CFO,Vadaketh Tom George ,卖出,9510普通股, $63.42
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-20,EVP & CFO,Vadaketh Tom George ,期权,9510普通股, $54.15
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2018-08-10 AccNo: 0001193125-18-245029 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-06,Director,KAUFTHAL ILAN ,卖出,5500普通股, $62.38
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-06,EVP & COO,Cavanagh Shawn ,卖出,37899普通股, $62.35
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-07,EVP & COO,Cavanagh Shawn ,卖出,8351普通股, $62.89
$凯姆布雷克斯(CBM)$ 内部交易: 2018-08-07,EVP & COO,Cavanagh Shawn ,期权,8351普通股, $40.65